• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rapidly growing, moderately differentiated HCC: A clinicopathological characteristic of HCC occurrence after IFN-free DAA therapy?

作者信息

Nakao Yasuhiko, Hashimoto Satoru, Abiru Seigo, Komori Atsumasa, Yamasaki Kazumi, Nagaoka Shinya, Saeki Akira, Bekki Shigemune, Kugiyama Yuki, Kuroki Tamotsu, Ito Masahiro, Nakao Kazuhiko, Yatsuhashi Hiroshi

机构信息

Clinical Research Center, National Hospital Organization (NHO) Nagasaki Medical Center, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Clinical Research Center, National Hospital Organization (NHO) Nagasaki Medical Center, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

出版信息

J Hepatol. 2018 Apr;68(4):854-855. doi: 10.1016/j.jhep.2017.11.011. Epub 2017 Nov 13.

DOI:10.1016/j.jhep.2017.11.011
PMID:29146486
Abstract
摘要

相似文献

1
Rapidly growing, moderately differentiated HCC: A clinicopathological characteristic of HCC occurrence after IFN-free DAA therapy?快速生长、中度分化的肝细胞癌：无干扰素直接抗病毒药物治疗后肝细胞癌发生的临床病理特征？
J Hepatol. 2018 Apr;68(4):854-855. doi: 10.1016/j.jhep.2017.11.011. Epub 2017 Nov 13.
2
Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.根治性治疗肝细胞癌后无干扰素直接作用抗病毒治疗丙型肝炎是否会导致 HCC 意外复发？日本红十字会医院肝脏研究组的一项多中心研究。
PLoS One. 2018 Apr 16;13(4):e0194704. doi: 10.1371/journal.pone.0194704. eCollection 2018.
3
The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience.接受或未接受聚乙二醇干扰素治疗的直接作用抗病毒药物治疗的丙型肝炎感染患者肝细胞癌早期发生和复发的风险：一项比利时的经验。
J Viral Hepat. 2017 Nov;24(11):976-981. doi: 10.1111/jvh.12726. Epub 2017 Aug 3.
4
Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.直接作用抗病毒药物降低丙型肝炎病毒相关肝细胞癌初始治疗后的肿瘤复发率。
Dig Dis Sci. 2017 Oct;62(10):2932-2942. doi: 10.1007/s10620-017-4739-z. Epub 2017 Sep 7.
5
Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C.基于干扰素和无干扰素治疗对慢性丙型肝炎患者肝细胞癌早期发生和复发的影响。
J Hepatol. 2017 Nov;67(5):933-939. doi: 10.1016/j.jhep.2017.05.028. Epub 2017 Jun 14.
6
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals.直接作用抗病毒药物治疗的丙型肝炎相关肝硬化中肝细胞癌的早期发生和复发。
J Hepatol. 2016 Oct;65(4):727-733. doi: 10.1016/j.jhep.2016.06.015. Epub 2016 Jun 24.
7
Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts.直接作用抗病毒药物对肝细胞癌复发影响的证据不足：来自三个法国国家研究署队列的数据。
J Hepatol. 2016 Oct;65(4):734-740. doi: 10.1016/j.jhep.2016.05.045. Epub 2016 Jun 7.
8
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.在纳入监测项目的肝硬化患者中，直接抗病毒治疗 HCV 后肝细胞癌的发生率。
Gastroenterology. 2018 Nov;155(5):1436-1450.e6. doi: 10.1053/j.gastro.2018.07.015. Epub 2018 Jul 19.
9
Rapidly growing hepatocellular carcinoma recurrence during direct-acting antiviral treatment for chronic hepatitis C.慢性丙型肝炎直接抗病毒治疗期间快速进展的肝细胞癌复发
Clin J Gastroenterol. 2018 Dec;11(6):497-500. doi: 10.1007/s12328-018-0876-y. Epub 2018 Jun 11.
10
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon.根治性切除或消融术后的肝细胞癌复发：HCV 清除的影响不依赖于干扰素的使用。
Aliment Pharmacol Ther. 2017 Jan;45(1):160-168. doi: 10.1111/apt.13821. Epub 2016 Oct 28.

引用本文的文献

1
High efficacy and safety of direct-acting antivirals for the treatment of chronic hepatitis C: A cohort study conducted in Vietnam.直接作用抗病毒药物治疗慢性丙型肝炎的高效性和安全性：在越南进行的一项队列研究。
Pharmacol Res Perspect. 2024 Oct;12(5):e70007. doi: 10.1002/prp2.70007.
2
No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy.与基于干扰素的疗法相比，直接抗病毒药物根除丙型肝炎病毒后肝细胞癌风险未增加。
Glob Health Med. 2022 Aug 31;4(4):216-224. doi: 10.35772/ghm.2022.01026.
3
Targeting the effect of sofosbuvir on selective oncogenes expression level of hepatocellular carcinoma Ras/Raf/MEK/ERK pathway in Huh7 cell line.
针对索磷布韦对Huh7细胞系中肝细胞癌Ras/Raf/MEK/ERK通路的选择性癌基因表达水平的影响。
Saudi J Biol Sci. 2022 Aug;29(8):103332. doi: 10.1016/j.sjbs.2022.103332. Epub 2022 Jun 1.
4
Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus.直接作用抗病毒治疗丙型肝炎后发生肝细胞癌患者的特征。
PLoS One. 2022 Jan 12;17(1):e0262267. doi: 10.1371/journal.pone.0262267. eCollection 2022.
5
Hepatocellular Carcinoma Risk, Outcomes, and Screening After Hepatitis C Eradication.丙型肝炎根除后的肝细胞癌风险、结局及筛查
Hepatol Commun. 2021 Sep;5(9):1465-1468. doi: 10.1002/hep4.1733.
6
Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR.丙型肝炎病毒持续病毒学应答后发生的肝细胞癌的特征及生存结果
Cancers (Basel). 2021 Jul 9;13(14):3455. doi: 10.3390/cancers13143455.
7
Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics.直接抗病毒药物治疗清除丙型肝炎病毒后肝细胞癌的风险：预测因素及表观遗传学的作用
Cancers (Basel). 2020 May 26;12(6):1351. doi: 10.3390/cancers12061351.
8
Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report.直接作用抗病毒药物治疗后成功的丙型肝炎病毒复发，随后发生肝细胞癌肉瘤样改变：一例报告。
J Med Case Rep. 2020 May 27;14(1):62. doi: 10.1186/s13256-020-02392-y.
9
Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment.与慢性丙型肝炎病毒感染相关的肝细胞癌机制及直接抗病毒治疗的影响
J Hepatocell Carcinoma. 2020 Apr 15;7:45-76. doi: 10.2147/JHC.S221187. eCollection 2020.
10
Serum miRNA Are Promising Biomarkers for the Detection of Early Hepatocellular Carcinoma after Treatment with Direct-Acting Antivirals.血清微小RNA是直接作用抗病毒药物治疗后早期肝细胞癌检测的有前景的生物标志物。
Cancers (Basel). 2019 Nov 11;11(11):1773. doi: 10.3390/cancers11111773.